{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:20:01Z","timestamp":1790770801458,"version":"4.1.0"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001922","name":"Efficacy and Mechanism Evaluation Programme","doi-asserted-by":"publisher","award":["12\/127\/127"],"award-info":[{"award-number":["12\/127\/127"]}],"id":[{"id":"10.13039\/501100001922","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13063-018-2487-9","type":"journal-article","created":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T00:14:55Z","timestamp":1519085695000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Catheter Ablation versus Thoracoscopic Surgical Ablation in Long Standing Persistent Atrial Fibrillation (CASA-AF): study protocol for a randomised controlled trial"],"prefix":"10.1186","volume":"19","author":[{"given":"Habib Rehman","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Kralj-Hans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouvik","family":"Haldar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toufan","family":"Bahrami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Clague","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"De Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darrel","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wajid","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Jarman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Gareth","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj","family":"Mediratta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raad","family":"Mohiaddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tushar","family":"Salukhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Lord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vias","family":"Markides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhiraj","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,20]]},"reference":[{"issue":"2","key":"2487_CR1","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1161\/CIRCULATIONAHA.105.595140","volume":"114","author":"Y Miyasaka","year":"2006","unstructured":"Miyasaka Y, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006;114(2):119\u201325.","journal-title":"Circulation"},{"issue":"7","key":"2487_CR2","doi-asserted-by":"publisher","first-page":"C108","DOI":"10.12968\/hmed.2015.76.7.C108","volume":"76","author":"WY Lim","year":"2015","unstructured":"Lim WY, Khan F. Management of atrial fibrillation: recommendations from NICE. Br J Hosp Med (Lond). 2015;76(7):C108\u201312.","journal-title":"Br J Hosp Med (Lond)"},{"issue":"8","key":"2487_CR3","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","volume":"129","author":"SS Chugh","year":"2014","unstructured":"Chugh SS, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129(8):837\u201347.","journal-title":"Circulation"},{"issue":"10","key":"2487_CR4","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1093\/europace\/eus305","volume":"14","author":"AJ Camm","year":"2012","unstructured":"Camm AJ, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation: developed with the special contribution of the European Heart Rhythm Association. Europace. 2012;14(10):1385\u2013413.","journal-title":"Europace"},{"issue":"5","key":"2487_CR5","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.hrthm.2017.01.032","volume":"14","author":"R Zakeri","year":"2017","unstructured":"Zakeri R, et al. The burden of proof: the current state of atrial fibrillation prevention and treatment trials. Heart Rhythm. 2017;14(5):763\u201382.","journal-title":"Heart Rhythm"},{"issue":"4","key":"2487_CR6","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S0735-1097(00)00886-X","volume":"36","author":"P Dorian","year":"2000","unstructured":"Dorian P, et al. The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy. J Am Coll Cardiol. 2000;36(4):1303\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"2487_CR7","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1161\/01.CIR.98.10.946","volume":"98","author":"EJ Benjamin","year":"1998","unstructured":"Benjamin EJ, et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98(10):946\u201352.","journal-title":"Circulation"},{"issue":"19","key":"2487_CR8","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","volume":"31","author":"European Heart Rhythm Association","year":"2010","unstructured":"European Heart Rhythm Association, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31(19):2369\u2013429.","journal-title":"Eur Heart J"},{"issue":"9","key":"2487_CR9","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1586\/14779072.2014.943189","volume":"12","author":"K Senoo","year":"2014","unstructured":"Senoo K, Lau YC, Lip GY. Updated NICE guideline: management of atrial fibrillation (2014). Expert Rev Cardiovasc Ther. 2014;12(9):1037\u201340.","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"3","key":"2487_CR10","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1136\/hrt.2002.008748","volume":"90","author":"S Stewart","year":"2004","unstructured":"Stewart S, et al. Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK. Heart. 2004;90(3):286\u201392.","journal-title":"Heart"},{"issue":"6","key":"2487_CR11","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1093\/europace\/eum120","volume":"9","author":"H Calkins","year":"2007","unstructured":"Calkins H, et al. HRS\/EHRA\/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society. Europace. 2007;9(6):335\u201379.","journal-title":"Europace"},{"issue":"4","key":"2487_CR12","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.hrthm.2011.12.016","volume":"9","author":"H Calkins","year":"2012","unstructured":"Calkins H, et al. 2012 HRS\/EHRA\/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society. Heart Rhythm. 2012;9(4):632\u201396.e21.","journal-title":"Heart Rhythm"},{"issue":"Suppl 1","key":"2487_CR13","first-page":"S8","volume":"86","author":"R Krittayaphong","year":"2003","unstructured":"Krittayaphong R, et al. A randomized clinical trial of the efficacy of radiofrequency catheter ablation and amiodarone in the treatment of symptomatic atrial fibrillation. J Med Assoc Thail. 2003;86(Suppl 1):S8\u201316.","journal-title":"J Med Assoc Thail"},{"issue":"21","key":"2487_CR14","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1001\/jama.293.21.2634","volume":"293","author":"OM Wazni","year":"2005","unstructured":"Wazni OM, et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA. 2005;293(21):2634\u201340.","journal-title":"JAMA"},{"issue":"4","key":"2487_CR15","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1001\/jama.2009.2029","volume":"303","author":"DJ Wilber","year":"2010","unstructured":"Wilber DJ, et al. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA. 2010;303(4):333\u201340.","journal-title":"JAMA"},{"issue":"11","key":"2487_CR16","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1016\/j.hrthm.2008.08.011","volume":"5","author":"C Pappone","year":"2008","unstructured":"Pappone C, et al. Atrial fibrillation progression and management: a 5-year prospective follow-up study. Heart Rhythm. 2008;5(11):1501\u20137.","journal-title":"Heart Rhythm"},{"issue":"7","key":"2487_CR17","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1586\/14779072.2013.811982","volume":"11","author":"G Stabile","year":"2013","unstructured":"Stabile G, et al. Antiarrhythmic therapy following ablation of atrial fibrillation. Expert Rev Cardiovasc Ther. 2013;11(7):837\u201342.","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"2","key":"2487_CR18","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.ijcard.2012.11.072","volume":"168","author":"S Haldar","year":"2013","unstructured":"Haldar S, et al. Contact force sensing technology identifies sites of inadequate contact and reduces acute pulmonary vein reconnection: a prospective case control study. Int J Cardiol. 2013;168(2):1160\u20136.","journal-title":"Int J Cardiol"},{"issue":"9","key":"2487_CR19","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1161\/hc0902.104712","volume":"105","author":"H Oral","year":"2002","unstructured":"Oral H, et al. Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation. Circulation. 2002;105(9):1077\u201381.","journal-title":"Circulation"},{"issue":"9A","key":"2487_CR20","doi-asserted-by":"publisher","first-page":"9K","DOI":"10.1016\/S0002-9149(00)01186-3","volume":"86","author":"M Ha\u00efssaguerre","year":"2000","unstructured":"Ha\u00efssaguerre M, et al. Mapping-guided ablation of pulmonary veins to cure atrial fibrillation. Am J Cardiol. 2000;86(9A):9K\u201319K.","journal-title":"Am J Cardiol"},{"issue":"12","key":"2487_CR21","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1161\/01.CIR.101.12.1409","volume":"101","author":"M Ha\u00efssaguerre","year":"2000","unstructured":"Ha\u00efssaguerre M, et al. Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci. Circulation. 2000;101(12):1409\u201317.","journal-title":"Circulation"},{"issue":"1","key":"2487_CR22","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1540-8167.2000.tb00727.x","volume":"11","author":"M Ha\u00efssaguerre","year":"2000","unstructured":"Ha\u00efssaguerre M, et al. Catheter ablation of chronic atrial fibrillation targeting the reinitiating triggers. J Cardiovasc Electrophysiol. 2000;11(1):2\u201310.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"19","key":"2487_CR23","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1056\/NEJMoa1408288","volume":"372","author":"A Verma","year":"2015","unstructured":"Verma A, et al. Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med. 2015;372(19):1812\u201322.","journal-title":"N Engl J Med"},{"issue":"8","key":"2487_CR24","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1093\/eurheartj\/eht457","volume":"35","author":"L Mont","year":"2014","unstructured":"Mont L, et al. Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study). Eur Heart J. 2014;35(8):501\u20137.","journal-title":"Eur Heart J"},{"issue":"3","key":"2487_CR25","doi-asserted-by":"publisher","first-page":"e002962","DOI":"10.1161\/CIRCEP.115.002962","volume":"9","author":"AS Jadidi","year":"2016","unstructured":"Jadidi AS, et al. Ablation of persistent atrial fibrillation targeting low-voltage areas with selective activation characteristics. Circ Arrhythm Electrophysiol. 2016;9(3):e002962. A published erratum appears in Circ Arrhythm Electrophysiol. 2016;9(6): e000015","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"1","key":"2487_CR26","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1161\/CIRCEP.114.001943","volume":"8","author":"D Scherr","year":"2015","unstructured":"Scherr D, et al. Five-year outcome of catheter ablation of persistent atrial fibrillation using termination of atrial fibrillation as a procedural endpoint. Circ Arrhythm Electrophysiol. 2015;8(1):18\u201324.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"7","key":"2487_CR27","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.hrthm.2012.02.016","volume":"9","author":"L Rivard","year":"2012","unstructured":"Rivard L, et al. Improved outcome following restoration of sinus rhythm prior to catheter ablation of persistent atrial fibrillation: a comparative multicenter study. Heart Rhythm. 2012;9(7):1025\u201330.","journal-title":"Heart Rhythm"},{"issue":"6","key":"2487_CR28","first-page":"4","volume":"53","author":"AV Ardashev","year":"2013","unstructured":"Ardashev AV, et al. Long-term results of radiofrequency catheter ablation of long-lasting persistent atrial fibrillation: five years of follow-up [in Russian]. Kardiologiia. 2013;53(6):4\u201311.","journal-title":"Kardiologiia"},{"issue":"11","key":"2487_CR29","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1111\/j.1540-8167.2005.00307.x","volume":"16","author":"M Ha\u00efssaguerre","year":"2005","unstructured":"Ha\u00efssaguerre M, et al. Catheter ablation of long-lasting persistent atrial fibrillation: critical structures for termination. J Cardiovasc Electrophysiol. 2005;16(11):1125\u201337.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2487_CR30","doi-asserted-by":"publisher","unstructured":"Haldar SK, et al. Characterising the difference in electrophysiological substrate and outcomes between heart failure and non-heart failure patients with persistent atrial fibrillation. Europace. 2017; https:\/\/doi.org\/10.1093\/europace\/euw380 .","DOI":"10.1093\/europace\/euw380"},{"issue":"4","key":"2487_CR31","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/jce.12606","volume":"26","author":"JW Jarman","year":"2015","unstructured":"Jarman JW, et al. Relationship between contact force sensing technology and medium-term outcome of atrial fibrillation ablation: a multicenter study of 600 patients. J Cardiovasc Electrophysiol. 2015;26(4):378\u201384.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"4","key":"2487_CR32","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.hrthm.2015.01.004","volume":"12","author":"M Fiala","year":"2015","unstructured":"Fiala M, et al. Sinus rhythm restoration and arrhythmia noninducibility are major predictors of arrhythmia-free outcome after ablation for long-standing persistent atrial fibrillation: a prospective study. Heart Rhythm. 2015;12(4):687\u201398.","journal-title":"Heart Rhythm"},{"issue":"1","key":"2487_CR33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1161\/CIRCULATIONAHA.111.074047","volume":"125","author":"LV Boersma","year":"2012","unstructured":"Boersma LV, et al. Atrial fibrillation catheter ablation versus surgical ablation treatment (FAST): a 2-center randomized clinical trial. Circulation. 2012;125(1):23\u201330.","journal-title":"Circulation"},{"key":"2487_CR34","doi-asserted-by":"crossref","first-page":"76","DOI":"10.12659\/MSMBR.894239","volume":"21","author":"A Sabashnikov","year":"2015","unstructured":"Sabashnikov A, et al. Position of totally thoracoscopic surgical ablation in the treatment of atrial fibrillation: an alternative method of conduction testing. Med Sci Monit Basic Res. 2015;21:76\u201380.","journal-title":"Med Sci Monit Basic Res"},{"issue":"6","key":"2487_CR35","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1016\/j.athoracsur.2012.06.010","volume":"94","author":"JH Sirak","year":"2012","unstructured":"Sirak JH, Schwartzman D. Interim results of the 5-box thoracoscopic maze procedure. Ann Thorac Surg. 2012;94(6):1880\u20134.","journal-title":"Ann Thorac Surg"},{"issue":"12 Suppl","key":"2487_CR36","doi-asserted-by":"publisher","first-page":"S64","DOI":"10.1016\/j.hrthm.2009.09.011","volume":"6","author":"JR Edgerton","year":"2009","unstructured":"Edgerton JR, et al. Totally thorascopic surgical ablation of persistent AF and long-standing persistent atrial fibrillation using the \u201cDallas\u201d lesion set. Heart Rhythm. 2009;6(12 Suppl):S64\u201370.","journal-title":"Heart Rhythm"},{"issue":"6","key":"2487_CR37","first-page":"506","volume":"38","author":"AW Chan","year":"2015","unstructured":"Chan AW, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Rev Panam Salud Publica. 2015;38(6):506\u201314.","journal-title":"Rev Panam Salud Publica"},{"key":"2487_CR38","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.ijsu.2014.12.007","volume":"13","author":"RA Agha","year":"2015","unstructured":"Agha RA, Altman DG, Rosin D. The SPIRIT 2013 statement \u2013 defining standard protocol items for trials. Int J Surg. 2015;13:288\u201391.","journal-title":"Int J Surg"},{"issue":"1","key":"2487_CR39","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1161\/CIRCEP.110.958033","volume":"4","author":"J Spertus","year":"2011","unstructured":"Spertus J, et al. Development and validation of the Atrial Fibrillation Effect on QualiTy-of-Life (AFEQT) Questionnaire in patients with atrial fibrillation. Circ Arrhythm Electrophysiol. 2011;4(1):15\u201325.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"22","key":"2487_CR40","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1093\/eurheartj\/ehm358","volume":"28","author":"P Kirchhof","year":"2007","unstructured":"Kirchhof P, et al. Outcome parameters for trials in atrial fibrillation: executive summary. Eur Heart J. 2007;28(22):2803\u201317.","journal-title":"Eur Heart J"},{"issue":"10","key":"2487_CR41","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1093\/europace\/euv309","volume":"17","author":"H Heidbuchel","year":"2015","unstructured":"Heidbuchel H, et al. Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation. Europace. 2015;17(10):1467\u2013507.","journal-title":"Europace"},{"issue":"3","key":"2487_CR42","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1365-2141.2011.08753.x","volume":"154","author":"D Keeling","year":"2011","unstructured":"Keeling D, et al. Guidelines on oral anticoagulation with warfarin - fourth edition. Br J Haematol. 2011;154(3):311\u201324.","journal-title":"Br J Haematol"},{"issue":"10","key":"2487_CR43","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.cjca.2014.08.001","volume":"30","author":"A Verma","year":"2014","unstructured":"Verma A, et al. 2014 focused update of the Canadian Cardiovascular Society Guidelines for the management of atrial fibrillation. Can J Cardiol. 2014;30(10):1114\u201330.","journal-title":"Can J Cardiol"},{"issue":"5","key":"2487_CR44","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1253\/circj.CJ-15-0319","volume":"79","author":"G Santarpia","year":"2015","unstructured":"Santarpia G, et al. Clinical significance of non-vitamin K antagonist oral anticoagulants in the management of atrial fibrillation. Circ J. 2015;79(5):914\u201323.","journal-title":"Circ J"},{"issue":"3","key":"2487_CR45","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.ejcts.2010.01.058","volume":"38","author":"A Yilmaz","year":"2010","unstructured":"Yilmaz A, et al. Completely thoracoscopic pulmonary vein isolation with ganglionic plexus ablation and left atrial appendage amputation for treatment of atrial fibrillation. Eur J Cardiothorac Surg. 2010;38(3):356\u201360.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"2","key":"2487_CR46","first-page":"A3938","volume":"155","author":"SPJ Krul","year":"2011","unstructured":"Krul SPJ, et al. Thoracoscopic treatment of atrial fibrillation [in Dutch]. Ned Tijdschr Geneeskd. 2011;155(2):A3938.","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"3","key":"2487_CR47","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/ejcts\/ezt385","volume":"45","author":"S Gelsomino","year":"2014","unstructured":"Gelsomino S, et al. Hybrid thoracoscopic and transvenous catheter ablation of atrial fibrillation. Eur J Cardiothorac Surg. 2014;45(3):401\u20137.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"4","key":"2487_CR48","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3109\/13645706.2011.615329","volume":"21","author":"JR de Groot","year":"2012","unstructured":"de Groot JR, et al. Epicardial confirmation of conduction block during thoracoscopic surgery for atrial fibrillation \u2013 a hybrid surgical-electrophysiological approach. Minim Invasive Ther Allied Technol. 2012;21(4):293\u2013301.","journal-title":"Minim Invasive Ther Allied Technol"},{"issue":"3","key":"2487_CR49","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/ccd.26782","volume":"89","author":"TR Betts","year":"2017","unstructured":"Betts TR, et al. Percutaneous left atrial appendage occlusion using different technologies in the United Kingdom: a multicenter registry. Catheter Cardiovasc Interv. 2017;89(3):484\u201392.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"7","key":"2487_CR50","doi-asserted-by":"publisher","first-page":"e003710","DOI":"10.1161\/CIRCEP.115.003710","volume":"9","author":"S Panikker","year":"2016","unstructured":"Panikker S, et al. Left atrial appendage electrical isolation and concomitant device occlusion to treat persistent atrial fibrillation: a first-in-human safety, feasibility, and efficacy study. Circ Arrhythm Electrophysiol. 2016;9(7):e003710.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"1","key":"2487_CR51","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.hrthm.2014.09.010","volume":"12","author":"S Panikker","year":"2015","unstructured":"Panikker S, et al. Left atrial appendage electrical isolation and concomitant device occlusion: A safety and feasibility study with histologic characterization. Heart Rhythm. 2015;12(1):202\u201310.","journal-title":"Heart Rhythm"},{"issue":"46","key":"2487_CR52","doi-asserted-by":"publisher","first-page":"3470","DOI":"10.1093\/eurheartj\/ehw048","volume":"37","author":"S Panikker","year":"2016","unstructured":"Panikker S, et al. Outcomes and costs of left atrial appendage closure from randomized controlled trial and real-world experience relative to oral anticoagulation. Eur Heart J. 2016;37(46):3470\u201382.","journal-title":"Eur Heart J"},{"issue":"4","key":"2487_CR53","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1161\/CIRCEP.113.000390","volume":"6","author":"DG Jones","year":"2013","unstructured":"Jones DG, et al. Impact of stepwise ablation on the biatrial substrate in patients with persistent atrial fibrillation and heart failure. Circ Arrhythm Electrophysiol. 2013;6(4):761\u20138.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2487_CR54","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ijcard.2015.04.241","volume":"191","author":"S Gunda","year":"2015","unstructured":"Gunda S, et al. Initial real world experience with a novel insertable (Reveal LinQ@Medtronic) compared to the conventional (Reveal XT@Medtronic) implantable loop recorder at a tertiary care center\u2014points to ponder! Int J Cardiol. 2015;191:58\u201363.","journal-title":"Int J Cardiol"},{"issue":"4","key":"2487_CR55","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1093\/europace\/euq511","volume":"13","author":"C Eitel","year":"2011","unstructured":"Eitel C, et al. Performance of an implantable automatic atrial fibrillation detection device: impact of software adjustments and relevance of manual episode analysis. Europace. 2011;13(4):480\u20135.","journal-title":"Europace"},{"issue":"4","key":"2487_CR56","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1080\/10976640601138805","volume":"9","author":"LE Hudsmith","year":"2007","unstructured":"Hudsmith LE, et al. Assessment of left atrial volumes at 1.5 Tesla and 3 Tesla using FLASH and SSFP cine imaging. J Cardiovasc Magn Reson. 2007;9(4):673\u20139.","journal-title":"J Cardiovasc Magn Reson"},{"issue":"5","key":"2487_CR57","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1080\/10976640500295516","volume":"7","author":"LE Hudsmith","year":"2005","unstructured":"Hudsmith LE, et al. Normal human left and right ventricular and left atrial dimensions using steady state free precession magnetic resonance imaging. J Cardiovasc Magn Reson. 2005;7(5):775\u201382.","journal-title":"J Cardiovasc Magn Reson"},{"issue":"10","key":"2487_CR58","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/jce.12199","volume":"24","author":"N Akoum","year":"2013","unstructured":"Akoum N, et al. Association of atrial fibrosis quantified using LGE-MRI with atrial appendage thrombus and spontaneous contrast on transesophageal echocardiography in patients with atrial fibrillation. J Cardiovasc Electrophysiol. 2013;24(10):1104\u20139.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"2","key":"2487_CR59","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jcmg.2015.10.015","volume":"9","author":"IM Khurram","year":"2016","unstructured":"Khurram IM, et al. Left atrial LGE and arrhythmia recurrence following pulmonary vein isolation for paroxysmal and persistent AF. JACC Cardiovasc Imaging. 2016;9(2):142\u20138.","journal-title":"JACC Cardiovasc Imaging"},{"key":"2487_CR60","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12938-015-0083-8","volume":"14","author":"A Giannakidis","year":"2015","unstructured":"Giannakidis A, et al. Rapid automatic segmentation of abnormal tissue in late gadolinium enhancement cardiovascular magnetic resonance images for improved management of long-standing persistent atrial fibrillation. Biomed Eng Online. 2015;14:88.","journal-title":"Biomed Eng Online"},{"issue":"7","key":"2487_CR61","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jcmg.2015.03.008","volume":"8","author":"P Suksaranjit","year":"2015","unstructured":"Suksaranjit P, et al. Incidental LV LGE on CMR imaging in atrial fibrillation predicts recurrence after ablation therapy. JACC Cardiovasc Imaging. 2015;8(7):793\u2013800.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"2487_CR62","doi-asserted-by":"publisher","first-page":"18","DOI":"10.4250\/jcu.2016.24.1.18","volume":"24","author":"SH Shin","year":"2016","unstructured":"Shin SH. Would left atrial strain provide a role as a new prognostigator for atrial fibrillation? J Cardiovasc Ultrasound. 2016;24(1):18\u20139.","journal-title":"J Cardiovasc Ultrasound"},{"issue":"2","key":"2487_CR63","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.1540-8175.2008.00794.x","volume":"26","author":"T Sahin","year":"2009","unstructured":"Sahin T, et al. Evaluation of left atrial appendage functions according to different etiologies of atrial fibrillation with a tissue Doppler imaging technique by using transesophageal echocardiography. Echocardiography. 2009;26(2):171\u201381.","journal-title":"Echocardiography"},{"issue":"3","key":"2487_CR64","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1540-8167.2011.02177.x","volume":"23","author":"C Hammerstingl","year":"2012","unstructured":"Hammerstingl C, et al. Left atrial deformation imaging with ultrasound based two-dimensional speckle-tracking predicts the rate of recurrence of paroxysmal and persistent atrial fibrillation after successful ablation procedures. J Cardiovasc Electrophysiol. 2012;23(3):247\u201355.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"7","key":"2487_CR65","doi-asserted-by":"publisher","first-page":"A493","DOI":"10.1016\/j.jval.2014.08.1464","volume":"17","author":"B Br\u00fcggenj\u00fcrgen","year":"2014","unstructured":"Br\u00fcggenj\u00fcrgen B, et al. Health state in patients with atrial fibrillation on new oral anticoagulants as assessed with the new EQ-5D-5L questionnaire at baseline and 12-month follow-up: PREFER in AF Registry [abstract]. Value Health. 2014;17(7):A493.","journal-title":"Value Health"},{"key":"2487_CR66","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1477-7525-8-13","volume":"8","author":"MT Dyer","year":"2010","unstructured":"Dyer MT, et al. A review of health utilities using the EQ-5D in studies of cardiovascular disease. Health Qual Life Outcomes. 2010;8:13.","journal-title":"Health Qual Life Outcomes"},{"issue":"6","key":"2487_CR67","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s40258-016-0262-1","volume":"14","author":"A Alshreef","year":"2016","unstructured":"Alshreef A, et al. Review of economic submissions to NICE Medical Technologies Evaluation Programme. Appl Health Econ Health Policy. 2016;14(6):623\u201334.","journal-title":"Appl Health Econ Health Policy"},{"issue":"2","key":"2487_CR68","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jval.2015.02.001","volume":"18","author":"SD Ramsey","year":"2015","unstructured":"Ramsey SD, et al. Cost-effectiveness analysis alongside clinical trials II\u2014an ISPOR Good Research Practices Task Force report. Value Health. 2015;18(2):161\u201372.","journal-title":"Value Health"},{"issue":"5","key":"2487_CR69","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/hec.678","volume":"11","author":"JS Hoch","year":"2002","unstructured":"Hoch JS, Briggs AH, Willan AR. Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost-effectiveness analysis. Health Econ. 2002;11(5):415\u201330.","journal-title":"Health Econ"},{"issue":"1","key":"2487_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jval.2013.09.003","volume":"17","author":"WG Goettsch","year":"2014","unstructured":"Goettsch WG, Enzing J. Review: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force [editorial]. Value Health. 2014;17(1):1\u20132.","journal-title":"Value Health"},{"issue":"9","key":"2487_CR71","doi-asserted-by":"publisher","first-page":"729","DOI":"10.2165\/00019053-200826090-00003","volume":"26","author":"L Longworth","year":"2008","unstructured":"Longworth L, Longson C. NICE Methodology for Technology Appraisals: cutting edge or tried and trusted? PharmacoEconomics. 2008;26(9):729\u201332.","journal-title":"PharmacoEconomics"},{"issue":"3","key":"2487_CR72","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1017\/S0266462313000330","volume":"29","author":"R Wong","year":"2013","unstructured":"Wong R, Paisley S, Carroll C. Assessing searches in NICE single technology appraisals: practice and checklist. Int J Technol Assess Health Care. 2013;29(3):315\u201322.","journal-title":"Int J Technol Assess Health Care"},{"issue":"2","key":"2487_CR73","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s11019-011-9376-2","volume":"16","author":"P Brown","year":"2013","unstructured":"Brown P, Calnan M. NICE technology appraisals: working with multiple levels of uncertainty and the potential for bias. Med Health Care Philos. 2013;16(2):281\u201393.","journal-title":"Med Health Care Philos"},{"issue":"1","key":"2487_CR74","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jval.2010.10.015","volume":"14","author":"JC Tosh","year":"2011","unstructured":"Tosh JC, Longworth LJ, George E. Utility values in National Institute for Health and Clinical Excellence (NICE) Technology Appraisals. Value Health. 2011;14(1):102\u20139.","journal-title":"Value Health"},{"key":"2487_CR75","first-page":"3","volume-title":"Reference Costs 2015\u201316","author":"Department of Health","year":"2016","unstructured":"Department of Health. Reference Costs 2015\u201316. London: Department of Health; 2016. p. 3\u201354. https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/577083\/Reference_Costs_2015-16.pdf"},{"key":"2487_CR76","volume-title":"Drug Tariff","author":"NHS Business Services Authority","year":"2017","unstructured":"NHS Business Services Authority. Drug Tariff. Newcastle upon Tyne, UK: NHS Business Services Authority; 2017."},{"key":"2487_CR77","volume-title":"Unit costs of health and social care 2016","author":"L Curtis","year":"2016","unstructured":"Curtis L, Burns A. Unit costs of health and social care 2016. Canterbury, UK: Personal Social Services Research Unit, University of Kent; 2016."},{"key":"2487_CR78","doi-asserted-by":"crossref","unstructured":"McKenna C, et al. Cost-effectiveness of radiofrequency catheter ablation for the treatment of atrial fibrillation in the United Kingdom. Heart. 2009;95(7):542\u20139.","DOI":"10.1136\/hrt.2008.147165"},{"key":"2487_CR79","doi-asserted-by":"publisher","unstructured":"Devlin N, et al. Valuing health-related quality of life: an EQ-5D-5L value set for England. Health Econ. 2017; https:\/\/doi.org\/10.1002\/hec.3564 .","DOI":"10.1002\/hec.3564"},{"issue":"5","key":"2487_CR80","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/hec.766","volume":"12","author":"A Briggs","year":"2003","unstructured":"Briggs A, et al. Missing ... presumed at random: cost-analysis of incomplete data. Health Econ. 2003;12(5):377\u201392.","journal-title":"Health Econ"},{"issue":"4","key":"2487_CR81","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/hec.1481","volume":"19","author":"T Shiroiwa","year":"2010","unstructured":"Shiroiwa T, et al. International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness? Health Econ. 2010;19(4):422\u201337.","journal-title":"Health Econ"},{"key":"2487_CR82","unstructured":"Lord J, et al. Economic modelling of diagnostic and treatment pathways in National Institute for Health and Care Excellence clinical guidelines: the Modelling Algorithm Pathways in Guidelines (MAPGuide) project. Health Technol Assess. 2013;17(58):v-vi, 1\u2013192."},{"issue":"4","key":"2487_CR83","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/jce.12603","volume":"26","author":"D Lin","year":"2015","unstructured":"Lin D, et al. Electrophysiologic findings and long-term outcomes in patients undergoing third or more catheter ablation procedures for atrial fibrillation. J Cardiovasc Electrophysiol. 2015;26(4):371\u20137.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"2","key":"2487_CR84","doi-asserted-by":"publisher","first-page":"e004549","DOI":"10.1161\/JAHA.112.004549","volume":"2","author":"AN Ganesan","year":"2013","unstructured":"Ganesan AN, et al. Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis. J Am Heart Assoc. 2013;2(2):e004549.","journal-title":"J Am Heart Assoc"},{"issue":"19","key":"2487_CR85","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/j.jacc.2012.04.060","volume":"60","author":"RR Tilz","year":"2012","unstructured":"Tilz RR, et al. Catheter ablation of long-standing persistent atrial fibrillation: 5-year outcomes of the Hamburg Sequential Ablation Strategy. J Am Coll Cardiol. 2012;60(19):1921\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"2487_CR86","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1016\/j.jacc.2013.01.069","volume":"61","author":"DG Jones","year":"2013","unstructured":"Jones DG, et al. A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure. J Am Coll Cardiol. 2013;61(18):1894\u2013903.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"2487_CR87","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/IMI.0b013e31826f0462","volume":"7","author":"C Muneretto","year":"2012","unstructured":"Muneretto C, et al. Successful treatment of lone persistent atrial fibrillation by means of a hybrid thoracoscopic-transcatheter approach. Innovations (Phila). 2012;7(4):254\u20138.","journal-title":"Innovations (Phila)"},{"issue":"4","key":"2487_CR88","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1093\/ejcts\/ezv180","volume":"49","author":"K Phan","year":"2016","unstructured":"Phan K, et al. Thoracoscopic surgical ablation versus catheter ablation for atrial fibrillation. Eur J Cardiothorac Surg. 2016;49(4):1044\u201351.","journal-title":"Eur J Cardiothorac Surg"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-018-2487-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T09:46:42Z","timestamp":1719827202000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-018-2487-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,20]]},"references-count":88,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2487"],"URL":"https:\/\/doi.org\/10.1186\/s13063-018-2487-9","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,20]]},"assertion":[{"value":"29 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study received ethical approval from the Bristol Research Ethics Committee Centre (NRES Committee South Central - Oxford A) on 5 March 2015 (REC reference []\/SC\/0023). All study participants are asked to sign a written informed consent form before taking part in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"HRK\u2019s salary was funded by the CASA-AF Trial. HRK has a non-financial competing interest for using data for a higher post-graduate degree. VM is a consultant for Biosense Webster. The other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"117"}}